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ABSTRACT: Metal ions are inextricably involved with nucleic acids due to their polyanionic nature. In 
order to understand the structure and function of RNAs and DNAs, one needs to have detailed pictures on 
the structural, thermodynamic, and kinetic properties of metal ion interactions with these 
biomacromolecules. In this review we first compile the physicochemical properties of metal ions found 
and used in combination with nucleic acids in solution. The main part then describes the various methods 
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developed over the past decades to investigate metal ion binding by nucleic acids in solution. This 
includes for example hydrolytic and radical cleavage experiments, mutational approaches, as well as 
kinetic isotope effects. In addition, spectroscopic techniques like EPR, lanthanide(III) luminescence, IR 
and Raman as well as various NMR methods are summarized. Aside from gaining knowledge about the 
thermodynamic properties on the metal ion-nucleic acid interactions, especially NMR can be used to 
extract information on the kinetics of ligand exchange rates of the metal ions applied. The final section 
deals with the influence of anions, buffers, and the solvent permittivity on the binding equilibria between 
metal ions and nucleic acids. Little is known on some of these aspects, but it is clear that these three 
factors have a large influence on the interaction between metal ions and nucleic acids. 
 
KEYWORDS: metal ions · ribozymes · RNA · methods · equilibrium constants 
 
 
1. INTRODUCTION 
Due to their polyanionic nature nucleic acids are unthinkable to exist without the close 
association of cationic counterions. Already the formation of secondary structures depends on 
the presence of metal ions because it requires the negatively charged backbones to come close to 
each other [1,2]. Larger RNAs form complicated tertiary structures with patches and cavities of 
increased negative electrostatic potential [3,4] that can not be stable without charge 
neutralization by associated cations. Most of the time, these ions are merely part of a diffuse ion 
atmosphere, providing the necessary charge neutralization but not interacting directly with the 
nucleic acid. Such ions can be well described by electrostatic continuum models based on the 
non-linear Poisson-Boltzmann (NLPB) equation [5]. A very small fraction of metal ions is 
coordinated tightly in buried binding pockets, where they are forced to release part or all of their 
hydration shells. In between the two extremes are those metal ions that interact with specific 
nucleic acid environments via a network of hydrogen bonds formed with their inner-shell water 
ligands and those, that are localized momentarily at electrostatically favorable sites like the 
major groove of RNA [3]. The wealth of loosely associated metal ions makes it difficult to single 
out the few more specifically bound metal ions.  
It does not help that affinities even for the more selective and specific metal ion binding 
sites in nucleic acids are usually low (102 and 104 M–1 [6–8]) compared to those observed in 
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proteins. Typically most of the coordination sites in an RNA will have very similar metal 
affinities and are therefore filled more or less simultaneously [7,9,10]. In addition, metal ions 
bound to nucleic acids usually keep at least a part of their hydration shell, which is rather an 
exception in proteins, and fast exchange with the solvent is a common feature. Thus, the very 
dynamic nature of nucleic acids is also reflected in the characteristics of their interactions with 
metal ions. Consequently, approaches that work very well for metal ion-protein binding are often 
not appropriate or not even possible for nucleic acids. Clearly, a much higher emphasis has to be 
set on the thermodynamics and kinetics as opposed to the structural features. The verification of 
conclusions derived from the solid state and crystal structures is of particular importance, if they 
are to be transferred to the solution state. 
Having said the above, a few more words on the importance of metal ion-nucleic acid 
interactions are necessary. Metal ions have stabilizing roles in DNA and RNA, but can also be 
responsible for large conformational changes. They can induce bending and unwinding [11,12] 
of nucleic acids. In addition, they are triggers for the B- to Z-transition in DNA (see also Chapter 
3) [13–16]. G-rich sequences in telomeres and in the untranslated regions (UTRs) close to genes 
form G-quadruplex structures with the help of metal ions (see Chapter 4), for which regulatory 
roles in replication, transcription, and translation are suspected [17]. Similarly, a Mg2+-sensing 
riboswitch in the 5'UTR regulates gene expression connected to metal homeostasis [18,19]. 
Apart from their structural role, coordinated metal ions are also often closely linked to the 
catalytic function of ribozymes. While it is not easy and not always possible to separate their 
structural and catalytic roles, metal ions have been identified in the active sites of most studied 
ribozymes (see e.g., [20–23]) and DNAzymes (see Chapter 8). Furthermore, they may be directly 
or indirectly involved in catalysis. The limited diversity of functional groups present in the four 
nucleotide building blocks of nucleic acids can be extended through the influence of metal ions 
[24], which can lead to a redistribution of electron densities, the shifting of pKa values [25–30], 
the favoring of transition state geometries or the stabilization of rare tautomers [29,31].  
It becomes thus evident how important a comprehensive knowledge is about the 
architectural, thermodynamic, and kinetic properties of metal ion-nucleic acid interactions for the 
understanding of the structure and function of nucleic acids. After a short introduction of the key 
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players, the involved metal ions (Section 2) and the nucleic acid ligating groups (Section 3), 
various methods, that have been employed in the characterization of coordination sites, binding 
kinetics, and binding affinities will be summarized and discussed (Sections 4, 5, and 6). 
2. LIGATING SITES FOR METAL IONS IN NUCLEIC ACIDS 
Metal ion coordination is influenced to a good part by the relative softness/hardness of potential 
metal ions and ligands, a concept that holds qualitative information on the electronegativity and 
polarizability of the groups [32,33]. Hard metal ions find suitable binding sites in the negatively 
charged non-bridging phosphate oxygens of the backbone and also in the exocyclic nucleobase 
oxygens [34], while the endocyclic nitrogens of the nucleobases are a preferred target of softer 
metal ions (Figure 1) [8,34–38]. Also available are the bridging phosphate oxygens and the 2'-
hydroxyl groups of sugar moieties [39,40]. The exocyclic amino groups of the nucleobases are 
usually not suitable liganding sites because of the delocalization of the lone pair into the 
aromatic ring.  
Steric factors also play a role, since especially in double-stranded helical regions some 
functional groups become inaccessible. In addition, the high rotameric freedom of the sugar-
phosphate backbone, which in principle permits the formation of bi- and tridentate 
macrochelates, is more restrained in double-stranded regions. 
insert Figure 1 close to here (width: 11.5 cm) 
3. METAL IONS TO BE CONSIDERED TO INTERACT WITH NUCLEIC ACIDS 
In the cell, kinetically labile metal ion-nucleic acid complexes predominate, which is to a large 
part due to the nature of the metal ions that are most abundant and freely available in the cellular 
environment (Table 1) [41–44]. Kinetically stable complexes on the other hand are employed in 
contexts procured by humans, like the administration of drugs or the development of nano-
devices. 
insert Table 1 close to here  
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3.1. Natural Metal Cofactors 
3.1.1. Dominance of Mg
2+
 
Mg2+ is the most important cofactor of nucleic acids inside the cell [24,37,45–49]. It is also the 
most abundant divalent metal ion inside the cell (Table 1), but this is not the only factor that 
predestines it for its role in nucleic acid structure and function. Mg2+ is a relatively hard Lewis 
base with a small ionic radius and correspondingly a high charge density. It has a strong 
preference for oxygen ligands, especially charged ones. In octahedral complexes the distances 
between the six oxygen ligands are close to their van-der-Waals radii, resulting in an exceptional 
stability [50]. This leads to reduced solvent exchange rates and increased solvation enthalpy, but 
at the same time also makes it a most suitable interaction partner for the non-bridging phosphoryl 
oxygens of the nucleic acid backbone, allowing them to pack particularly closely [51], which is a 
prerequisite for the physiological folding of large RNAs. In accordance, a nearly perfect 
correlation between the cleavage rate of the hammerhead ribozyme [52,53] and the metal ion 
affinity towards phosphate monoesters can be established [34]. Nevertheless, such a correlation 
cannot be established, for example, for the glmS ribozyme [54], indicating a crucial influence of 
further ligand sites. 
Partial dehydration of Mg2+ is enthalpically costly and so direct coordination contacts to 
nucleic acids are only favorable when more than one ligand in a suitable geometry replaces the 
water molecules [55,56]. Therefore, it is far more common that Mg2+ interacts through 
outersphere contacts of its first hydration shell, especially in the case of the nucleobase sites like 
the endocyclic nitrogens and exocyclic oxygens [57].  
3.1.2. Monovalent Ions 
In terms of abundance, Mg2+ is surpassed by the monovalent K+, which is present in the cell at 
140 mM, but also by Na+ present at 10 mM concentration, a value comparable to that of Mg2+. 
Outside the cell Na+ and K+ concentrations are reversed (Table 1). These monovalent ions are far 
less apt to establish a close packing of the negative charges of the nucleic acid backbone. Usually 
a largely unspecific role as general charge screeners is attributed to K+ and Na+, even if there are 
also examples of specific monovalent ion binding sites (Figure 2) [58,59]. 
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insert Figure 2 in color close to here (width: 11.5 cm) 
3.1.3. Influences of Metal Ions Other than Mg
2+
 and K
+
 
Na+ and Ca2+ levels in the cell are lower than those of Mg2+ and K+. Na+ is expected to share the 
task of unspecific charge screening together with K+. Ca2+ is used as a signaling molecule in the 
cell and therefore it is tightly regulated, e.g., by the fast uptake into the endoplasmic reticulum 
(ER) and mitochondria [60]. Tightly controlled are also typical protein metal cofactors like 
Fe2+/3+, Zn2+, and Cu+/2+ [41,61,62], with significant free cellular concentrations only in case of 
intoxication, disease or drug treatment [63]. Nonetheless, also low levels of a metal ion are able 
to influence nucleic acids if binding specificity and affinity are favorable, as is shown for 
example by the allosteric inhibition of a group II intron when 5% Ca2+ compete against 95% 
Mg2+ [64]. In the same way other low-abundance metal ions might be involved in the regulation 
of RNA function [34]. In the following, we will shortly mention some relevant metal ions that 
are frequently studied in association with nucleic acids, highlighting their distinctive properties 
with respect to Mg2+ or K+. Those latter two unfortunately are hard to detect and to characterize 
by most methods due to their low molecular weight and spectroscopic silence and hence, a 
variety of metal ions has been used as substitutes in different settings. 
The interactions of metal ions in general with nucleic acids are governed by complex 
stabilities according to the Irving-Williams series [65] and Martin's Stability Ruler [66,67], by 
the relative affinities for oxygen versus nitrogen ligands [8] and by first shell hydration 
enthalpies (Table 2) [10,68–78]. Ca2+, for example, shares the preference of Mg2+ for phosphate 
oxygen ligands, but is larger in size and thus compatible with higher coordination numbers and a 
more loose packing of ligands. Ca2+ can inhibit Mg2+-dependent enzymes and ribozymes (e.g., 
[64,79–82]). Li+ has a charge density and ligand preference comparable to Mg2+, but favors 
tetragonal geometries. Mn2+ on the other hand, which is very similar to Mg2+ regarding both size 
and preferred coordination geometry, has a more balanced affinity for nitrogen and oxygen 
ligands and a ligand exchange rate 100 times faster than Mg2+ (Table 2). It is used as a 
paramagnetic probe in EPR as well as NMR experiments. Cd2+ is a much softer metal ion and 
therefore much more likely to interact through innersphere contacts with nucleobase nitrogens. 
In addition, it also has a higher inclination to form macrochelates than the other metal ions 
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mentioned so far [37,57,83]. Cd2+ is significantly larger than Mg2+, but its thiophilicity [84–86] 
makes it a popular choice for metal-rescue experiments with phosphorothioates despite a serious 
caveat [86]. Zn2+ is also very thiophilic and more similar in size to Mg2+, but engages in variable 
coordination geometries [87]. Tl+ has been employed as a substitute for K+, making use either of 
its thiophilicity or of the abundant spin 1/2 nucleus of 205Tl+. The kinetically inert complex 
[Co(NH3)6]
3+ can be of help to probe [Mg(H2O)6]
2+ binding sites, even if binding affinity and 
hydrogen bonding capacities differ because of the higher charge and the nature of the ammonium 
ligands, respectively. [Co(NH3)6]
3+ is, e.g., found to bind to the major groove of tandem G·U 
wobble pairs (Figure 2d). 
insert Table 2 close to here  
(reduce font size such that it fits landscape-wise on the width of a page) 
Metal ions other than Mg2+ have been shown to support catalysis of natural ribozymes, 
some even at increased reaction rates, like Mn2+, Co2+, Zn2+, and Cd2+ in the case of the RzB and 
Schistosoma Hammerhead ribozymes [52,53] or Ca2+ in the case of the antigenomic form of the 
hepatitis delta virus (HDV) ribozyme [88]. While in the case of the two Hammerhead ribozymes, 
the observed cleavage rates correlate with the respective phosphate affinity of the metal ion 
applied [34], in the case of the glmS ribozyme, no such correlation is observed [54]. Although 
such "more exotic" metal ions do not occur freely in the cell and are usually employed under in 
vitro conditions above their physiological abundances, locally or in secluded compartments of 
the cell, metal ions like Zn2+ might also in vivo reach concentrations where the described effects 
become significant.  
3.2. Expanding the Natural Metal Repertoire of Catalytic RNAs and DNAs  
While on the one hand ribozyme catalysis is in many cases promoted by a variety of divalent 
metal ions or even monovalent ions alone, on the other hand so far only a limited subset of metal 
ions have been shown to be specifically required in naturally occurring ribozymes, a fact that 
seems surprising in light of the diverse metal ion binding capabilities and selectivities of various 
in vitro selected ribozymes and DNAzymes. The latter have been shown to discriminate against 
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Mg2+, while selecting for Ca2+ [89–91], Cu2+ [92–94], Co2+ [95], Zn2+ [96], Mn2+ [94], Pb2+ [97], 
Ni2+ [98] or a small subgroup of transition metal ions [99]. By the same means extraordinarily 
selective DNA biosensors for various metal ions have been engineered [100,101] (see also 
Chapter 8).  
3.3. Kinetically Stable Metal Ion Complexes 
In Nature, the structural integrity and function of nucleic acids is maintained by metal ions with 
intermediate to fast water exchange rates (Table 2). Consequently, these ions also form 
kinetically rather labile complexes with RNA and DNA. The action of metal-based drugs, on the 
other hand, usually depends on the irreversible association of metal ion complexes to DNA. 
Following the historical discovery of the anticancer properties of Cisplatin, cis-(NH3)2PtCl2 
(Figure 2e) [102], many other Pt2+, but also Pt4+, Ru3+, Ga3+ and Ti4+ complexes have been 
investigated (see also Chapters 2 and 7) with regard to their anticancer activity [103]. 
3.4. Metallated Nucleic Acids for Nanotechnology 
DNA, as a self-assembling molecule, has long been of interest for nanotechnological 
applications. The addition of metal ions can switch nucleic acids between two conformations 
(e.g., from single- to double-strand, or from hairpin to duplex), which has been taken advantage 
of for designing biosensors for metal ions (e.g., [104–107] and Chapter 8) and recently even 
logical AND and OR gates [108]. Furthermore, metal ions can modify the physico-chemical 
properties of nucleic acids and thereby extend their natural functional repertoire. While DNA 
alone possesses only marginal conductivity, one idea is that the incorporation of metal ions to 
natural or artificial nucleotides in double-stranded nucleic acid structures might yield useful 
molecular wires or magnets [109]. 
Incorporation of metal ions such as Zn2+, Co2+, or Ni2+ into DNA yielding so-called M-
DNA has been proposed to make DNA more conductive [110–112]. There is still some 
controversy about this [113] as well as about the definite structure of M-DNA and the situation 
of metals therein [114–116].  
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In contrast, the structure of Hg2+- and Ag+-mediated base pairs, where the metal replaces 
the imino protons at the N3 position in U-U/T-T base pairs or stabilizes C-C mismatches, 
respectively, has been well established by NMR measurements and UV melting studies 
[104,117–119]. The binding of an Au3+ ion in the center of a G-C base pair has been observed in 
the crystal structure of an RNA [120].  
The incorporation of artificial nucleotides that can serve as metal ion binding sites can help 
to fine-tailor the conformation and stabilities of nucleic acid structures. For instance, Müller, 
Sigel, and coworkers have demonstrated the incorporation of Ag+ ions into imidazole and 
triazole base pairs (Figure 2f) [118,121]. Clearly, with artificial nucleotides one can also further 
extend the range of possible metal binding sites. Examples are Cu2+-hydroxypyridone base pairs 
[122] and salen metal base pairs (Cu2+, Mn2+/3+, Fe3+, Ni2+, and VO2+) [123,124]. In a few cases 
artificial metal ion binding nucleotides have also been incorporated in polynucleotides with 
modified backbones like PNA (peptide nucleic acid; see also Chapter 12) and GNA (glycol 
nucleic acid) (see [125] and references therein). For a more detailed discussion on artificial base 
pairs we refer the reader to Chapters 10 and 11 of this volume and recent reviews by Müller and 
Clever and Shionoya [125,126]. 
4. STRUCTURAL CHARACTERIZATION OF METAL ION BINDING SITES 
As summarized in the above section, the range of metal ions that have been observed to interact 
with nucleic acids in one or another specific context is very wide. The structural characterization 
of their binding sites, their precise localization, and the number and type of associated ligands in 
solution have been studied by a combination of chemical, biochemical and spectroscopic 
methods that will be discussed in the following. 
4.1. Chemical and Biochemical Methods 
Well-established biochemical and chemical methods are used to map metal ion binding sites 
through backbone cleavage. However, information on structural features of the interaction sites 
can be inferred only indirectly, by studying the effect on ribozyme kinetics or conformation of 
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mutated functional groups or the substitution of hard ligands or metals by soft ones. Nonetheless, 
many metal ion binding sites could be predicted by these methods, which only later on were 
confirmed in X-ray crystal structures. The strength of chemical and biochemical methods lies in 
the identification and characterization of catalytically important metal ion binding sites in 
ribozymes and their applicability also to very large molecules. 
4.1.1. Metal Ion-Induced Hydrolytic Cleavage 
Many metal ions catalyze the cleavage of phosphodiester bonds. The cleavage pattern in a large 
RNA thus holds information about the location of metal ion binding sites. The cleavage depends 
on local geometry and is mainly thought to take place through an "in-line" nucleophilic attack of 
the metal at a 2'-hydroxyl group that is followed by transesterification (Figure 3) [127,128]. A 
2',3'-cyclic phosphate and a 5 hydroxyl group result of this cleavage, analogous to the reaction 
catalyzed by the small phosphodiester-cleaving ribozymes. The cleavage rates have been shown 
to be pH dependent, thus indicating the involvement of the metal hydroxides [129]. Mg2+ has a 
very low cleavage capacity at neutral pH (the pKa of Mg(H2O) 6
2+  is 11.4; Table 2) and 
consequently, transition metal and lanthanide ions are normally used as probes. Pb2+ is much 
more efficient than Zn2+ and Mn2+ [130], but all three have been used to localize metal-RNA 
interaction sites [131–134]. Lanthanide(III) ions are especially suitable and employed frequently 
as probes because their charge makes them bind rather tightly and pKa values close to neutral 
facilitate efficient cleavage [135–137].  
insert Figure 3 close to here (width: 11.5 cm) 
Cleavage assays require 5'- or 3'-32P-end-labeling of the RNA. The cleavage products are 
separated by denaturing PAGE and the cleavage patterns subsequently used to determine the 
binding sites. Conclusions, however, are not straightforward because different factors determine 
the sites of cleavage. Firstly, favorable backbone geometries for cleavage are more common in 
single-stranded and loop regions than in double-stranded helices [128,138]. On the other hand, 
strong relevant binding sites in a more rigid environment with an unfavorable geometry for in-
line attack might be missed. Secondly, while lanthanide and transition metal ions often seem to 
bind at the same sites as Mg2+ [136], they still are able to adopt diverse coordination geometries 
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or have divergent ligand preferences. Hence, one might miss the most specific binding sites 
while non-Mg2+ binding sites might be detected. Competition experiments with Mg2+ can help to 
identify physiologically relevant binding sites, but they are not able to distinguish effects of 
structural changes induced by a Mg2+ binding non-competitively at a different site from effective 
lanthanide displacement by Mg2+. Cleavage experiments are thus prone to false negative as well 
as false positive results, but in combination with other experiments can give valuable 
information.  
4.1.2. Metal Ion-Induced Radical Cleavage 
Alternatively, metal ion binding sites can be probed with Fe2+ [139], taking advantage of the 
Fenton reaction [140,141]. In the presence of H2O2 Fe
2+ is oxidized to Fe3+ generating short-
lived hydroxyl radicals that will lead to backbone cleavage in the near proximity of the Fe2+/3+ 
binding sites. Fe3+ is then reduced again to Fe2+ by sodium ascorbate. Fe2+ compares well to 
Mg2+ in terms of radius and coordination geometry (Table 2) [142] and can compete for Mg2+ 
binding sites [139]. However, it has to be kept in mind that their different Pearson hardness will 
in many cases lead to divergent binding preferences.  
4.1.3. Mutational Approaches to Determine Metal Ligands 
Once putative binding sites have been determined, various nucleotide analogs [143] can help to 
identify more details about a coordination site. Functional groups of a specific nucleobase, sugar 
or phosphate moiety are modified or removed and the effect can be monitored, e.g., by looking at 
the metal ion cleavage pattern. Alternatively, the metal ion binding sites that are important for 
catalysis or essential for structural integrity can be inferred from the catalytic competence or 
overall conformation of the mutated nucleic acid as determined in enzymatic or electrophoretic 
mobility shift assays, respectively.  
Nucleotide analogue interference mapping (NAIM) [144] is an efficient way to 
systematically probe the importance of RNA functional groups [10]. In combination with metal 
ion switch experiments this method is also useful in establishing putative metal ion binding sites 
(see Figure 4 and Section 4.1.4.) [145–148]. T7 RNA polymerase is used to randomly introduce 
phosphorothioate nucleotides or nucleotide analogs (NTPS) at levels of less than one 
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substitution per transcript. Afterwards those mutants, in which activity or another screenable 
characteristic has been abolished, are separated from the pool of transcripts. Iodine cleavage and 
subsequent analysis on the gel reveal the positions of the mutated nucleotides [144].  
insert Figure 4 close to here (width: 11.5 cm) 
The method can, for example, be used to identify metal-coordinating phosphate groups 
through metal rescue as described below, with the restriction that only RP phosphorothioates can 
be studied as T7 polymerase selects against the other diastereomer [149]. Basu et al. have used a 
combination of X-ray crystallography and NAIM to identify a monovalent metal ion binding site 
in the Tetrahymena ribozyme P4-P6 domain [58]. They showed the rescue of a 6-thioguanosine 
mutation by Tl+, a thiophilic K+ substitute. 
4.1.4. Metal Ion Switch Experiments 
The divergent ligand preferences of different kinds of metal ions are the basis of metal ion 
switch experiments. Mg2+ and Mn2+ prefer the harder oxygen ligands, while Cd2+, Zn2+ and Pb2+ 
display a pronounced preference for the softer aromatic-nitrogen and especially sulfur sites [84–
86,150,151]. Mutations that exchange oxygen for sulfur or nitrogen groups can significantly 
suppress Mg2+ binding, but the adverse effects can often be rescued by Cd2+ or Mn2+. The 
method is especially useful in identifying catalytically involved metal ions (see also recent 
reviews [152] and [10]) and is usually thought to be limited to the analysis of directly 
coordinated metal ions. However, Basu and Strobel report the rescue of outerspherely 
coordinated binding sites by Mn2+ [153]. Since Mg2+ preferentially binds to phosphoryl oxygens, 
the most common mutation in this kind of experiment is the exchange of phosphates for 
phosphorothioates, but also 2'-OH substitution by NH2 has been used [154].  
Evaluation of metal rescue experiments is complicated by several possible adverse effects. 
Firstly, there are the inherent physico-chemical differences (e.g., size, hydrogen bonding, 
coordination geometry, electronegativity) not only of the switched metal ions but also of the 
switched ligands. Sulfur, for example, is larger than oxygen and thus the introduction of a 
phosphorothioate by itself can already alter local structure and/or distort a metal ion binding site. 
Secondly, ribozymes usually present many other possible interaction sites for the rescuing metal, 
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at which binding can influence the structure and function significantly. To exclude them as well 
as possible, experiments are normally performed against a background of Mg2+. Evaluation is 
usually based on relative rate constants that take into account the catalytic rates of all four 
combinations of the unmodified and modified ribozyme with Mg2+ and with the rescuing metal 
ion (equation 1) [152,155].  
 krel = 
 
k
M2+ ,S/N
k
Mg2+ ,S/N






k
M2+ ,O
k
Mg2+ ,O






1
 (1) 
kM2+,S/N and kMg2+,S/N are the rate constants of the modified ribozyme in the presence of the 
substituting metal ion or Mg2+, respectively, and kM2+,O  and kMg2+,O the corresponding rates in the 
wild-type ribozyme. Using an approach termed thermodynamic fingerprint analysis (TFA) that 
combines metal ion rescue with kinetic analysis, Herschlag, Picirilli, and coworkers were able to 
establish how many metal ions are involved in catalysis by the Tetrahymena group I intron 
([154] and more detailed descriptions in [152,156]). By examining the influence of mutations at 
several sites in the RNA substrate and the cofactor GTP both in the absence and presence of 
Mn2+, the authors were able to determine three sites with different Mn2+ binding affinities, 
thereby confirming the presence of three different metal ions. In the case of the Hammerhead 
ribozyme, a thio-rescue experiment gave valuable clues about the structure of the transition state 
active site: The analysis of enzyme kinetics in single and double mutants in a thio-rescue 
experiment strongly supports a bridging metal ion between a previously described metal ion 
binding site and the cleavage site [157]. 
4.1.5. Kinetic Isotope Effect 
Compared to the modifications mentioned in the previous paragraphs, substitution of an atom 
with a heavier isotope of the same element is a very small, but nonetheless detectable intrusion in 
a system. The substitution can have an enhancing or decreasing effect on a reaction and thereby 
reveal information about the transition state structure [158,159]. Recently, this method has been 
applied to the transition state of RNase P [160,161]. The detected H2
18O heavy isotope effect 
agrees perfectly with the results obtained from the Mg2+-catalyzed cleavage of the model 
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compound 5-p-nitrophenylphosphate (T5PNP). This indicates that the cleavage mechanism in 
RNase P involves the same transition state as in T5PNP, where the H2
18O is directly coordinated 
to the metal ion [160]. In the future the better availability of specifically 18O-enriched 
nucleotides might open the field for a wider application [162,163]. 
4.2. Spectroscopic Methods 
4.2.1. Electron Paramagnetic Resonance 
Electron paramagnetic resonance (EPR) spectroscopy can be very useful for the characterization 
of metal ion-nucleic acid interaction in several ways. However, most EPR methods require the 
sample to be frozen. In solution at room temperature, EPR can provide information on the 
populations of free and bound metal ions and thereby binding affinities as well as cooperativities 
but structural details are not accessible [164–166]. At low temperature in a frozen sample, 
hyperfine interactions between the unpaired electron spin of a paramagnetic metal ion and the 
spin of the nuclei are able to hint at the coordination environment of the metal ion. Two more 
advanced applications, ENDOR (electron-nuclear double resonance spectroscopy) and ESEEM 
(electron spin echo envelope modulation) can even reveal details about the number and type 
(14N/15N, 1H/2H, 31P) of the immediate coordinating partners within a radius of 6–7 Å. For a 
more detailed description of the techniques we refer the interested reader to recent expert 
reviews by DeRose and coworkers [167,168].  
Since EPR is limited to paramagnetic metal ions, Mn2+ is a popular object of study due to 
its similarities with Mg2+ (Table 2). Both its electron and nuclear spin are 5/2, but degeneration 
leads to a spectrum with only 6 characteristic main lines. The exchange of metal ion-coordinated 
water molecules for RNA ligands is accompanied by subtle perturbations of the spectrum. As 
signals from differently bound metal ions will always overlay, an unambiguous analysis usually 
requires sample conditions with only one prominent metal ion binding site. A single tightly 
bound Mn2+ ion can, for example, be observed in a background of monovalent ions in the 
Hammerhead ribozyme: ESEEM spectroscopy allowed the precise localization of the metal ion 
at a site with specifically 15N-labeled guanine, the determination of further liganding sites and 
also of the hydration level [169]. In a different approach, multiple Mn2+ binding sites in the 
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Diels-Alder ribozyme were gradually silenced by Cd2+, allowing thus their individual 
characterization [166]. 
4.2.2. Lanthanide(III) Luminescence 
The luminescence of lanthanide(III) metal ions is sensitive to the direct coordination 
environment and thus can yield information on the metal ion binding pocket. This method is 
mentioned here for the sake of completeness but we refer the reader to Chapter 6 of this volume 
for a detailed description. 
4.2.3. X-ray Absorption Spectroscopy  
The coordination environment of tightly bound transition metal ions can be characterized in 
detail in solution by X-ray absorption spectroscopy (XAS) methods like XANES and EXAFS. 
XANES (X-ray absorption near edge structure) is sensitive to the average oxidation state of the 
metal in the sample, while EXAFS (extended X-ray absorption fine structure) allows the 
deduction of the number and type of ligands as well as coordination geometry and metal-ligand 
atom distances. Detection is possible in dilute solution and metal ions that are classified as 
spectroscopically silent (like Na+, K+, Mg2+, or Ca2+, Cu+, and Zn2+) are accessible [170].  
Nucleic acids are not optimally suited for XAS investigations, considering the 
predominantly weak interactions and the coexistence of many metal ion binding sites in most 
constructs. Nonetheless, higher-affinity binding sites, like the ones in the G-quadruplex channel 
[171] or in a short RNase P helix P4 model [172] can be characterized in remarkable detail, not 
to forget complexes of kinetically more inert metal ions [173,174]. 
4.2.4. Vibrational Spectroscopies 
Metal ion binding is reflected in changes of the vibrational bands of nucleobase, sugar, and 
phosphate constituents, which can be measured by infrared (IR) and Raman spectroscopy. While 
IR depends upon oscillating dipole moments and is influenced by all types of non-symmetrically 
bonded atoms, Raman signals derive from the inelastic scattering of photons and occur when 
there are changes in polarizability. The latter are therefore especially sensitive to electron-rich or 
multiply bonded groups. In addition, water absorbs in the IR range but is not observed in Raman 
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spectra. Thus, the two methods can yield useful complementary information on a fast timescale 
and in all physical states [175,176]. Discrete vibrational bands for base, sugar and phosphate 
groups can be observed, albeit only as an average signal of all conformational states in the 
sample. Isotopic labeling is an approach to partly alleviate this problem [177,178].  
FT-IR (Fourier-transform infrared) spectroscopy and Raman spectroscopy have been 
employed to semiquantitatively follow metal ion-induced conformational changes [13,179,180] 
and identify primary binding sites for a variety of metal ions in RNA and DNA [181–187]. By 
Raman spectroscopy the largest metal ion-dependent changes are observed in the phosphodiester 
signals. The symmetric stretching of non-bridging phosphate oxygens has recently been 
proposed to contain quantitative information about the degree of innersphere coordinated metal 
ions in RNA [188]. Christian et al. [188] find that while electrostatic and hydrogen interactions 
yield only an attenuation, innersphere coordination is accompanied by a shift of the Raman 
signal, an effect that could in addition also be roughly correlated to the electronegativity and the 
Pearson hardness of the respective metal ion. Raman spectroscopy in solution requires rather 
concentrated and highly pure samples, restricting this method to the analysis of smaller 
constructs. Raman crystallography or microscopy is an approach that can significantly increase 
signal intensity and reduce background signals. It allowed the identification of inner- and 
outersphere coordinated metal ions in the HDV ribozyme [189–191].  
4.2.5. Nuclear Magnetic Resonance Methods 
Nuclear magnetic resonance (NMR) spectroscopy has provided the three-dimensional structures 
of hundreds of RNA and DNA molecules. Its restriction in terms of molecular size – compared 
to X-ray crystallography – is outweighed by the singular capacity to reveal not only structure and 
conformation, but also local and global dynamics of macromolecules in solution in a quantitative 
manner. The big advantage compared to other spectroscopic methods in solution is the resolution 
of the individual nuclei at almost every single position in a polynucleotide chain, allowing the 
simultaneous site-specific characterization of multiple metal ion binding sites.  
Most approaches are based on indirect observations of metal ion induced changes in the 
nucleic acid binding sites. The most abundant isotopes of hydrogen and phosphorus (1H and 31P) 
both have nuclear spins of 1/2 as it is the case with 15N and 13C. The latter are widely used in 
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isotopically enriched nucleotides instead of the natural isotopes 14N and 12C. But also the direct 
observation of NMR-active metal nuclei can help in the structural and thermodynamic 
characterization of metal binding sites [192,193]. Metal ion-nucleic acid interactions can have 
repercussions on chemical shifts, relaxation properties and scalar couplings of involved NMR 
active nuclei [194]. In addition, NOEs (nuclear Overhauser effects) to the protons of popular 
metal ion mimics, [Co(NH3)6]
3+ and NH 4
+ , can denote coordination sites [195]. 
4.2.5.1. Chemical Shift Perturbations: Chemical shifts are the most straightforwardly 
measurable factor in a NMR experiment (Figure 5). Binding of metal ions can influence the 
chemical shift in two ways: Either through direct deshielding of a nucleus or through 
shielding/deshielding effects upon conformational changes of the neighborhood that result from 
a binding event. The latter effect is especially prevalent for 1H shifts and reduces the accuracy 
with which a binding site can be localized, but on the other hand it is also a highly sensitive flag 
to define the binding pocket. In the case of smaller structures that do not undergo significant 
conformational changes upon metal ion interaction, 1H shift perturbations can be used as good 
indicators of metal ion binding sites [6,196,197]. Imino proton shifts are mostly well resolved 
and can often be monitored satisfactorily in 1D spectra. However, the observable ones are 
usually part of a Watson-Crick hydrogen bonding pattern and then not in close proximity to the 
metal ion binding atom. In addition, the chemical shift of imino protons is very sensitive to 
temperature and accessibility of bulk water, which may falsify results.  
insert Figure 5 close to here (width: 11.5 cm)  
(must fit on one page together with the legend) 
In this case, homo- or heteronuclear 2D NMR spectra can often yield more significant shift 
perturbations from the non-exchangeable protons. Mg2+-induced 1H chemical shift changes are 
usually not larger than 0.1–0.2 ppm [6,7,197] at limiting metal concentrations of ~10–20 
equivalents and perturbations of 13C chemical shifts are similarly small in general [197–200]. 
Chemical shifts induced by [Co(NH3)6]
3+ are slightly more pronounced due to the higher charge 
and associated 10 times stronger binding affinity [201]. Unfortunately, exchange rates of 
commonly employed metal ions are often in the intermediate regime on the NMR time scale [84] 
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leading to a general broadening of the lines already at lower concentrations that can impede the 
analysis of chemical shift changes. 
With 31P, nucleic acids contain a second highly sensitive and abundant spin 1/2 nucleus in 
addition to protons, whose only disadvantage is the low signal dispersion. Most 31P resonances 
cluster in the small region between –3 to –1 ppm and only a few with non-standard backbone 
torsion angles can be resolved from the rest [202]. 31P resonances can be unambiguously 
assigned by the site-specific incorporation of a non-bridging 17O that efficiently broadens the 
signal of the adjacent 31P [203], an approach which has been employed, e.g., by Hansen et al. 
[204] to pinpoint a binding site in a Hammerhead ribozyme. Alternatively, 31P resonances from 
the crowded bulk region can be resolved by the incorporation of phosphorothioates, which have 
a 31P resonance shifted by ~60 ppm [203,205], allowing to observe effects of metal ion binding 
to selected sites in the phosphate backbone [206]. Coordination of Cd2+ to a phosphorothioate, 
for example, will lead to an upfield shift of the 31P resonance by a few ppm in both RP and SP 
diastereomers, as has been observed for both the A9/G10.1 and scissile phosphate locations in 
the hammerhead ribozyme [207,208] in agreement with the results of biochemical studies by 
Wang et al. [157]. However, such experiments have to be interpreted with care because the 
introduction of a sulfur atom might also create a new or specially shifted binding site. 
Considering the unfavorable NMR characteristics of oxygen isotopes, 15N is the only 
nucleus in nucleic acids that can serve as a probe for the detection of an innersphere coordination 
site. In addition, 15N is straightforwardly observable by NMR spectroscopy. This explains why 
with 15N, compared to 1H, 13C and 31P, much higher chemical shift perturbations can be 
observed. Direct coordination to nucleobase nitrogens is confirmed in Hg2+-mediated thymine 
base pairs in DNA by 30 ppm 15N downfield shifts [117] as well as by Ag+ coordination to 
imidazole nucleotides [118]. Also the more labile coordination of Cd2+ and Zn2+ ions to N7 
induces 20 ppm shifts in 1D 15N experiments [209–211]. An initial broadening of the 15N 
resonance is attributed to the exchange between free and bound states. At higher, saturating Cd2+ 
concentrations the peak grows sharper again. Resonances for the adjacent purine 13C8 and 1H8 
are perturbed less but still significantly [172], which is not observed in outersphere coordination 
[212,213]. Since direct observation of the low sensitivity nucleus 15N can be lengthy, the 
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recording of 2D [1H,15N]-HSQC can be advantageous, while at the same time enhancing the 
resolution. On the basis of 2J-[1H,15N]-HSQC experiments Erat et al. have proposed that the 
combined information of 1H and 15N shifts and characteristic broadening can be used to identify 
inner- and outersphere binding events [214]. The empirically collected knowledge agrees well 
with theoretical calculations, confirming that 15N chemical shifts are a valid means to determine 
the coordination mode [215,216].  
4.2.5.2. Paramagnetic Effects: The large magnetic moment of an unpaired electron of a 
paramagnetic metal ion species efficiently relaxes nuclei in their immediate environment (Figure 
5b) [172,217,218]. The effect is strictly distance-dependent (relative to r–6) and leaves less room 
for ambiguity than chemical shift perturbations. Paramagnetic line broadening information can 
even be included as weak distance restraints in molecular dynamics calculations [197]. Mn2+ 
exchanges very fast between the free and bound form and can therefore effectively relax a whole 
molecule at substoichiometric concentrations. μM amounts are usually enough to detect site-
specific line-broadening effects. Mn2+ is most widely used because of its likeness to Mg2+ (e.g., 
[219–221]), but also Co2+ and Ni2+ are suitable paramagnetic probes [98,222]. 
4.2.5.3. NOE Crosspeaks to [Co(NH3)6]
3+
 and NH 4
+ : [Co(NH3)6]
3+ is a mimic for 
[Mg(H2O)6]
2+ [223] and has been used in a wide range of studies [172,200,201,224–226]. 
Similarly, NH 4
+  can be used as a substitute for monovalent metal ions [195]. Both compounds 
possess protons that are amenable for direct observation of inter-molecular NOE crosspeaks 
(Figure 5d) to nucleic acid protons in a radius smaller than 6 Å. In the most common case 
tumbling of the cation in the binding site and exchange with the unbound state are fast on the 
chemical shift time scale and all [Co(NH3)6]
3+/NH 4
+  protons resonate at a single frequency. G-
quadruplex structures are an exception, displaying a binding site with on-off rates slow enough 
to allow observation of separate resonances for free and bound ammonium [227,228]. The tight 
binding even significantly slows down the usually fast proton exchange of ammonium [195]. It is 
advantageous to employ 15N-labeled NH 4
+  because it not only avoids the quadrupolar 14N 
nucleus, but also allows for heteronuclear HSQC experiments that detect the exchange of ions 
between binding sites and the solvent [229]. Structural information, however, can be inferred in 
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both fast and slow exchanging cases. From the NOE cross-peaks of [Co(NH3)6]
3+ or NH 4
+  weak 
distance restraints can be extracted and integrated in molecular dynamics simulations to infer 
binding sites [45]. 
4.2.5.4. Direct Detection of NMR-Active Metal Isotopes: A good number of the metal ions 
that have been studied in association with nucleic acids have at least one NMR-active isotope. 
Unfortunately many of them, including the biologically most relevant 23Na+, 39K+, and 25Mg2+, 
have half-integer spins > 1/2. Fast quadrupolar relaxation usually restricts their use in solution 
NMR experiments to the study of kinetic and thermodynamic features by line shape analysis (see 
also Sections 5 and 6) [230–234] and pushes them more into the field of solid state NMR, which 
is better suited to handle the large quadrupolar effects.  
Spin 1/2 isotopes are available in 52Fe, 107Ag, 109Ag, 111Cd, 113Cd, 195Pt, 199Hg, 203Tl, 205Tl, 
and 207Pb. Many have wide chemical shift ranges and can give useful information about 
coordination geometry and ligand atom identity, as has been shown in proteins [235,236]. In 
nucleic acids, however, their use is most often restricted by the problem of weak binding and fast 
exchange. An exception is again the high-affinity binding of monovalent metal ions to G-
quadruplex structures that even permitted the direct observation of separate peaks for the bound 
and unbound species of 23Na+, 39K+, and 85Rb+, which was not thought possible so far [192,237].  
205Tl+ is a very useful NMR substitute for K+ and Na+ due to its high natural abundance 
(70%) and high sensitivity [238]. Basu et al. observe two well separated 205Tl+ peaks for the 
bound and unbound species in a G-quartet [239]. In a subsequent work Gill et al. even managed 
to measure small scalar 1H-205Tl+ couplings of < 1 Hz between the ion and imino and aromatic 
protons, which allow the precise localization of metal ions in a G-quadruplex structure [193].  
Such direct couplings could not be observed between 113Cd2+ and 15N upon coordination of 
the metal ion to an N7 in the tandem G·A base-pair motif of the hammerhead ribozyme 
[209,212], which is attributed to the fast exchange of Cd2+. The coordination of Ag+ ions 
between imidazole nucleotide analogs in a DNA duplex on the other hand is stable enough to 
observe a 87 Hz 1J(15N,107/109Ag) coupling indirectly in the splitting of the nitrogen signal 
(Figure 5c) [118].  
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5. DETERMINATION OF BINDING KINETICS 
Metal ions interact with nucleic acids on a very wide range of time scales. Fast exchange (ms to 
μs range) dominates the dynamic interactions of the majority of alkali and alkaline earth metal 
ions. On the other extreme, metal complexes effective in cancer treatment are characterized by 
particularly slow kinetics that can be in the order of hours or days [240]. Mg2+ is special with 
regard to its water-ligand exchange rate of ~2·105 s–1 being four orders of magnitude slower than 
that of most of the main group metal ions, but also significantly slower than many transition 
metal ions [241]. 
5.1. Nuclear Magnetic Resonance 
The appropriate approach for establishing binding kinetics is determined by the association-
dissociation rate of the metal ion, which can be fast, intermediate or slow on the respective time 
scale accessible to the employed method. For example, what is considered fast on the NMR 
(~10–1–10–9 s) or EPR (~10–4–10–8 s) time scale will still be slow in IR (~10–13 s) or UV (~10–15 
s) spectroscopy [42]. In the case of slow exchange, separate signals can be observed for each 
exchanging species, while fast exchange only displays one averaged signal (Figure 6). NMR has 
proven the most versatile tool to determine thermodynamic and kinetic parameters on different 
time scales. Most of the relevant exchange processes in nucleic acids happen in fast exchange ( > 
103 s–1) relative to the NMR chemical shift time scale. In this regime, the NMR signal has a 
chemical shift that corresponds to the population-weighted average of the chemical shifts of the 
bound and unbound forms. A concentration-dependent movement of the signal can be used to 
deduce affinity constants (see Section 5.2). If the exchange is moderately fast (too fast would be 
k–1 > 40 |bound–unbound| [242]) a full line-shape analysis can give on- and off-rates of metal 
binding as well as equilibrium dissociation constants [242,243]. Relaxation rates and line-shapes 
of the quadrupolar nuclei 23Na, 25Mg, and 43Ca are modulated by their interactions with larger 
molecules and have been used in a number of studies to characterize binding kinetics, 
cooperativity and co-solute dependence [230–232,234,244–246]. 
insert Figure 6 close to here (width: 6 cm) 
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Magnetic relaxation dispersion (MRD) experiments allow the probing of molecular 
motions over a wide range of time scales by recording autorelaxation rates of quadrupolar nuclei 
at various different field strengths [247,248]. In this way the residence times of small molecules 
like H2O (through 
2H or 17O) [249] or metal ions (especially well suited is 23Na+) on the surface 
of a biomolecule can be determined under fast exchange conditions. By MRD experiments, Halle 
and colleagues confirmed the binding of 23Na+ in the minor groove of DNA A-tracts by showing 
that binding is blocked by the minor groove binding drug netropsin [250,251]. Results support 
the existence of relatively long-lived 23Na+ (50 ns [250]; 10 ns to 100 μs [251]) and 58Rb+ (0.2 ± 
0.1 μs [251]) ions. 
When NH 4
+  or [Co(NH3)6]
3+ are used as metal ion mimics, cross-relaxation experiments 
on the basis of the nuclear Overhauser effect (NOESY, ROESY) can be used to observe fast 
exchange between different binding sites and the solvent [11]. Together, the peak magnitudes 
and the absence of an observable change in the dominant bulk chemical shift of ammonium 
protons allow the deduction of upper and lower limits for the exchange rate, but no exact 
quantification. 
Intermediate exchange is characterized by severely broadened resonances. As long as the 
resonances are still detectable, temperature-dependent changes and line-shape analysis can yield 
exchange rates. Mg2+ interactions with RNA often occur on an intermediate time scale leading to 
a gradual broadening of all resonances in the course of a metal titration [6,7,10,196,252]. 
In the region of slow exchange on the chemical shift time scale each exchanging species 
gives a separate signal that can be monitored individually. Only very few metal binding motifs 
have been characterized so far that are able to slow down exchange so significantly. Among 
them are the strong binding sites in the stem of G-quadruplex structures, for which lifetimes can 
be exceptionally long on the NMR chemical shift timescale [227,228] and which have been 
studied extensively due to their compact size.  
In slowly exchanging systems, the frequency differences between bound and unbound 
species directly indicate lower limits for residence times, even if the fully bound state is usually 
not reached. In this way directly observed G-quadruplex channel-bound and free 23Na+ and 85Rb+ 
resonances gave conservative lower residence limits of 90 μs and 17 μs, respectively [237]. 
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Similarly, the shifts of the K+-substitute 205Tl+ allows estimation of exchange rates in a G-
quartet, where also one especially slowly exchanging ion could be identified through the 
exceptionally small line width [239]. Slow exchange is also amenable to saturation transfer 
experiments. Monitoring the efficiency of magnetization transfer from free 205Tl+ to bound 205Tl+ 
for varying saturation times, bound lifetimes between 80 ± 10 ms and 155 ± 65 ms for different 
binding sites on a G-quadruplex were found [193]. Employing 15NH 4
+ , 15N–1H Nz exchange 
HSQC experiments at incremented mixing times allow the observation of different ammonia 
species – free and bound via inner- and outersphere binding in the channel permitting the 
quantification of the exchange rates between the individual species [229,253,254]. A 
considerably slower exchange for 15NH 4
+  than for Na+ is observed.  
The binding rates of the anticancer drug cis-diamminedichloroplatinum(II) and its trans 
isomer, however, are on a completely different time scale than any of the slowly-exchanging 
examples above. To illustrate this: binding kinetics in the range of 10–5 s–1 are determined from 
the gradually growing peaks of the mono- and bifunctional Pt2+-DNA adducts over many hours 
[255]. 
5.2. Further Methods 
NMR is the by far most used method to study metal ion binding kinetics in nucleic acids and 
there are only few examples where a different approach has led to the determination of 
association-dissociation rates. Dynamics in the μs-range are fast on the NMR, but not necessarily 
on the EPR time scale and thus exchange processes that are averaged out in the former, might be 
resolved in the latter [167].  
Labuda and Pörschke have used the intrinsic fluorescence of the wyosine (Wye) 
nucleobase, which is a natural modification of guanine, to establish binding kinetics of Mg2+ and 
Ca2+ to the anticodon loop in tRNA [256]. By a temperature jump method, relaxation parameters 
in the absence and presence of metal ions were determined. Interestingly, the rate constants for 
Ca2+ binding in general and Mg2+ innersphere binding particularly were found to be in the ms 
range. 
Where experimental methods reach their limits in terms of resolution and exchange rates, 
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molecular dynamics (MD) simulations can give complementary information on the metal 
binding to known nucleic acid structures. However, the force field description of di- and 
multivalent cations is much more demanding than that of monovalent ions [257]. In addition, at 
present, simulations are limited to below μs time scales, which is too short to observe, e.g., the 
dehydration of Mg2+ [258]. What is possible in terms of kinetics, however, is the evaluation of 
the residence times of the more easily dehydrated K+ and Na+ with nucleic acid surfaces that 
happen on the ps to ns time scale [259–262] and for longer-lived bound metal species the 
estimation of lower boundaries of residence times [263]. 
6. DETERMINATION OF BINDING AFFINITIES 
Two challenges are faced in the thermodynamic analysis of metal ion binding to nucleic acids. 
Firstly, metal ion binding is inextricably interwoven with the folding and structural stability of 
nucleic acids and the one cannot be studied without affecting the other [264]. Secondly, usually 
there are only few specific binding sites with higher affinity and they coexist with a large 
background of weak, transient electrostatic interactions that are not easily accounted for in 
simple binding polynomials [265]. Both problems can sometimes be alleviated by determining 
apparent affinity constants under moderately high monovalent salt conditions, assuming that then 
the nucleic acid conformation will not significantly change any more upon addition of the metal 
ion to be analyzed and that all unspecific interaction sites will be saturated by the monovalent 
ion.  
Metal ion affinities have been inferred from a range of different observables, like 
thermodynamic stabilities of the nucleic acid fold measured by UV melting curves [266–269] or 
the thermodynamics of folding of the hammerhead ribozyme by isothermal titration calorimetry 
(ITC) [270]. Qualitative and quantitative assessment of sequence specific ion binding to DNA A-
tracts has been undertaken based on the reduced effective charge that can be detected by free 
solution capillary chromatography [271,272]. Apparent metal affinity constants have been 
determined from observed rate constants of ribozyme catalysis in many cases (e.g., 
[154,157,273–275]). An approach based on the gas-phase fragmentation of metal-nucleic acid 
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complexes in ESI-MS (electrospray ionization mass spectrometry) was recently applied to 
determine binding affinities to the thrombin binding aptamer [276]. In addition, the ratio of 
bound and unbound metal ions, as determined by fluorescent indicators, AES (atomic emission 
spectroscopy), NMR, EPR or lanthanide luminescence, in dependence of metal ion 
concentration, yields information on binding affinities (see Sections 6.1–6.3). 
These various approaches differ in their ability to derive quantitative information, their 
ability to distinguish between multiple coexisting binding sites and their limits in terms of 
macromolecule size. All of the above methods yield signals that are an overlay of all the binding 
sites present in the system. Analysis of the dependence of the bound and free metal ion 
concentrations on the total metal ion concentration by, e.g., Hill or Scatchard plots can help to 
disentangle them to some extent to determine classes of binding sites with similar affinities and 
their occupancies and give information about binding cooperativity. However, one should be 
aware that reciprocal plots, like Scatchard or Eadie-Hofstee plots can lead to wrong values, as 
some experimental data points can obtain too much weight depending on their distribution [277]. 
In addition, this approach is in many cases challenged by the interdependence of RNA folding 
and metal ion binding [264]. Aside from that, there is usually also a restriction to simpler model 
molecules with one or only few strong binding sites. While the size restriction is also true for 
NMR, this method has one advantage over all the others: It allows to separately monitor binding 
events at several individual binding sites in a molecule and to determine intrinsic binding 
affinities (see Section 6.3). 
6.1. Stoichiometric Methods – "Ion Counting" 
So-called "ion counting" methods detect the free metal ion concentration in a sample, from 
which the number of ions strongly bound to the nucleic acid can be deduced. This can be useful 
to establish the number of strong divalent metal ion binding sites in a high-salt background 
[143], but also to evaluate the affinities of different metal ions with respect to each other. Here, 
fluorescent indicators have been widely used to determine free metal ion concentrations [278–
280]. However, such dyes are usually restricted to the detection of one specific kind of metal ion. 
Recent methodological progress has made AES a very valuable tool in this regard, able to detect 
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a far wider range of mono- and divalent cations and also anions, thereby more completely 
accounting for the ion cloud around polynucleotides [281,282]. Irrespective of the way of 
detection, those methods are based on the equilibration of the nucleic acid-containing solution 
(by dialysis or ultrafiltration spin columns) against a buffer solution with well defined metal 
content. After the equilibrium is reached, metal ion concentrations in both solutions are 
measured and the number of metal ions retained per nucleic acid molecule can be determined 
[278,282]. 
6.2. Relative Affinities by Competition Experiments 
EPR, lanthanide luminescence or NMR experiments can be used to directly sense the bound 
metal ions. All these methods, however, are restricted to certain metal ions each: EPR mainly to 
Mn2+, which can differ significantly from Mg2+ in binding affinities for nucleic acid ligands 
[167], luminescence measurements to lanthanide(III) ions, mainly Tb3+, and NMR to NMR-
active nuclei. Competition experiments, where the observable ion is displaced stepwise by 
increasing concentration of another (silent) metal ion, can yield relative apparent affinities for a 
wider range of ions [275,283–285]. The same method can also be applied, for example, in Tb3+ 
cleavage experiments: The change in cleavage intensity with increasing amounts of competing 
Mg2+ can in principle be used to calculate Mg2+ binding affinity at specific sites [9,10]. 
6.3. Calculating Site-Specific Intrinsic Binding Affinities from NMR Chemical Shifts 
While slow exchange can make things easier in the study of binding kinetics, for the 
determination of affinity constants by NMR fast exchange can be advantageous. Observable 
nuclei that are affected by the fast exchange between the metal-bound and metal-free state 
exhibit one resonance at the population-weighted average position. Titration with a metal ion 
will shift the free-to-bound equilibrium and thereby the position of the peak. Similarly, the peak 
width of a resonance will be affected when the titrated metal ion is paramagnetic. If a resonance 
is influenced only by one single association-dissociation event, the chemical shift change or 
change in peak width, respectively, plotted against metal ion concentration can be fitted by a 1:1 
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binding isotherm using e.g. a Levenberg-Marquardt [7,196,286,287] or a Newton-Gauss [288] 
algorithm and binding constants can be deduced. This has been widely used for small complexes 
[25,27,40,86,289–291], as well as for more complicated nucleic acids [7]. 
However, if there is more than one binding site all having similar affinities, as is usually 
always the case for nucleic acids, the sites will compete for the metal ions. Therefore the 
effective metal ion concentration that is available for each binding site at each titration step is 
lower than what was actually added and calculated affinities will always be underestimated. An 
iterative approach proposed by Erat, Sigel et al. circumvents this caveat (Figure 7) [7,9,10]. The 
first step is the grouping of resonances, according to their initial affinity constants and additional 
information like Mn2+ line broadening, into probable binding sites. The average binding 
constants for those sites are used to determine a refined free metal ion concentration. The newly 
determined metal concentration is again inserted into the calculation of binding constants. These 
steps are repeated until the calculated affinities do not significantly change any more. 
insert Figure 7 close to here (width: 11.5 cm) 
Proton resonances lend themselves to this kind of study because of their easy and fast 
acquisition, comparably good signal dispersion in 2D experiments and high sensitivity to 
changes in their environment. However, there are some factors that can hamper the 
determination of binding constants in this way. Firstly, bound Mg2+ exchanges with the solvent 
on the intermediate NMR chemical shift time scale and lines can get too broad to follow at 
higher concentrations. Secondly, the presumption that each binding site is affected by a single 
binding event is often not true, especially for protons. A second binding event close-by or a 
structural rearrangement, even if it is small, can make the data unusable. And thirdly, of course, 
the mapping of binding sites requires that resonances have been assigned. 
7. EFFECTS OF OTHER FACTORS 
7.1. Effect of Anions  
The stabilities of commonly employed metal salts have to be kept in mind when characterizing 
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and quantifying cation-nucleic acid interactions. Adverse effects are possible especially in the 
high, non-physiological concentrations of certain salts that are part of many setups and can 
interfere with the collection of quantitative information. For example, the group of DeRose 
observes significant coordination of Mn2+ to Cl– at high Cl– concentrations [167]. Similarly, Cd2+ 
is known to form a rather stable CdCl+ complex in aqueous solution: Consequently, an increase 
in Cd2+ affinity towards RNA of 0.8 log unit for log KA values has been observed for M
2+ 
binding to the bulge region within the catalytic domain 5 of a group II intron ribozyme when 
using 100 KClO4 instead of 100 mM KCl [292]. 
Compared to cations, information on anion binding to nucleic acids is rather scarce, even 
though they too have been shown to be present in the first coordination shell of nucleic acids. 
Molecular dynamics simulations and a thorough evaluation of crystal structures [293–295] have 
identified anions (Cl–, SO 4
2 , ClO 4 , and PO 4
3  as the most frequently employed anions in 
crystallization buffers and MD simulations). These anions replace water molecules close to 
nucleobase amino groups as well as to endocyclic nitrogens and 2'-OH groups. The same authors 
[295] also speculated that anions occupy sites that are also possible binding sites for the 
negatively charged functional groups of proteins, drugs or phosphate backbone groups from a 
distant nucleic acid strand.  
Anions are also found in close association with metal ions [293,295]. In some cases local 
arrangements where the anion is situated between two cations suggest an interdependence of 
binding, where the anion facilitates the close approach of two positive charges (Figure 8) [295]. 
Close contact of two Mg2+ ions is observed in many ribozyme active sites. In some cases, based 
on abnormally short metal-metal distances and molecular dynamics simulations, the existence of 
a bridging hydroxide has been suspected [296–298].  
insert Figure 8 in color close to here (width: 11.5 cm) 
Nucleic acids are commonly studied in solutions containing Cl–, SO 4
2 , ClO 4  or PO 4
3 , yet 
little is known about the differential effects those anions might have on their physical properties. 
A study of 25Mg relaxation revealed a different behavior in the presence of Cl– and SO 4
2 , which 
is attributed to a lyotropic effect [234]. A difference between these two anions was also observed 
in the first step of splicing in a group II intron [299]. While ammonium chloride stimulated 
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branching readily, ammonium sulfate did so only after a long lag phase in reactivity.  
7.2. Effect of Buffers 
Metal ion complexation by a buffer is often neglected, but in fact rather common and can 
severely hamper the quantitative analysis of binding events (e.g., [300,301]). Many buffers 
commonly employed in biological applications interact significantly with metal ions [302-309]. 
The preparation of RNA or DNA samples for further experiments usually involves high amounts 
of Tris (2-amino-2-hydroxymethyl-propane-1,3-diol) and Hepes [N-(2- hydroxyethyl)-
piperazine-N-2-ethanesulfonic acid] [310], e.g., in transcription and electrophoresis running 
buffers, that have to be removed carefully before any quantitative investigation of metal ion 
binding is attempted [307] (Figure 9). When applying Mg2+, buffers like Tris or Bistris [bis-(2-
hydroxy-ethyl)-amino-tris(hydroxymethyl)-methane] have relatively little influence, but this 
changes when Ca2+ [39,311], 3d metal ions or Cd2+ are applied [39,57,307,308], which show an 
increased affinity, e.g., by about 2 log units for Cd2+, if compared with Mg2+ [307]. Phosphate, 
which is frequently employed as a buffer in spectroscopic or biochemical experiments of nucleic 
acids, also interacts with metal ions strongly enough to falsify measurements of intrinsic affinity 
constants [36] or of reaction rates [312–315], an observation that holds for other buffers as well 
[312,316]. Consequently, one is often forced to work in buffer-free media [312,317,318]. 
insert Figure 9 close to here (width: 11 cm) 
Not only metal ions engage in interactions with buffer molecules, but also nucleic acids 
have been shown to form complexes with certain buffers, which can lead to complex formation 
or affect the conformation [319,320]. Thus also the formation of nucleic acid ternary complexes 
with buffers and metal ions, like they have been observed for nucleotides [57,307,308,311,321] 
and in human serum albumin [322], is a possibility that should be kept in mind when studying 
the interactions of metal ions and nucleic acids. 
7.3. Effects of Solvent Permittivity and Co-solutes to Mimic Macromolecular Crowding 
Two more factors are of importance when evaluating the significance of in vitro findings for 
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metal ion nucleic acid interactions of biological systems: The dilute aqueous reaction conditions 
under which most in vitro investigations of nucleic acids take place are quite unrealistic with 
regard to the molecular crowding present in the cytoplasm and inside cellular organelles 
[323,324]. Also dielectric constants at the surface and even more in the interior of proteins and 
nucleic acids differ significantly from the value of about 80 for water. Depending on the local 
environment values between 20 to 70 can occur [325–330].  
Studies in an aqueous solution of 1,4-dioxane have been used to simulate the reduced 
permittivity of such conditions and found an overall increased Mg2+ affinity to a short RNA 
hairpin [331]. Such an increase was also observed for the binding of Cu2+ to single nucleotides in 
dioxane-enriched solutions [332]. To simulate the crowded cellular environment, Nakano et al. 
investigated the stability and catalytic activity of a minimal hammerhead ribozyme with 
PEG8000 as co-solute [333,334]. The authors find that large neutral co-solutes stabilize the 
tertiary structure and enhance catalytic rates especially at low Mg2+ concentrations. In general, 
molecular crowding is expected to reduce the high concentrations of Mg2+ that are usually 
required for the correct folding of RNA molecules under in vitro conditions, when considering 
the situation in a living cell [335]. 
8. CONCLUDING REMARKS 
Compared to the situation in most metalloproteins, metal ion binding to nucleic acids is rather 
weak and of a highly dynamic nature. The reason for such true binding equilibria are the nature 
of the ligands – mainly phosphates, aromatic ring nitrogen atoms, and bridging water molecules 
– and of the metal ions, i.e. alkaline and alkaline earth metal ions. In addition, the metal ions of 
interest are mostly spectroscopically silent, which makes their detection at the coordinating sites 
very difficult. Taken together, the detailed characterization of metal ion binding to nucleic acids 
is rather challenging. In this review we summarized the methods applied nowadays with the aim 
to understand metal ion binding in solution and compiled the literature for the more interested 
reader. It is obvious that we are not only far from understanding this fascinating interaction and 
thus also the folded structure and mechanism of action of nucleic acids, but also that the methods 
applied carry numerous caveats. Most studies rely on the application of other metal ions than, 
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e.g., Mg2+, which automatically means that the system under investigation has been altered. 
Every kind of metal ion has its distinct coordinating properties and thus also the functional RNA 
will slightly (or possibly more seriously) change its structure and other properties. In order to 
draw conclusions how the system works in its wild-type form, i.e., in the presence of Mg2+, one 
has to know exactly how the coordinating properties of the different metal ions change according 
to their position in the periodic table. Some efforts in this direction have been made and some 
progress was achieved in the past few years [8,34,37]. However, to make things more 
complicated, it also turned out that there seems to be no general rule: While for two different 
hammerhead ribozymes a clear correlation was found between cleavage rate and phosphate 
affinities of specific metal ions [34], no such correlation could be established for the glms 
ribozyme, which is about the same size and uses the same mechanism of cleavage [54]. 
Consequently, it looks like as if every ribozyme, sometimes even of the same class but from 
different organisms, has its own specificities for metal ion binding. 
Most methods applied today find their origin in applications in the metalloprotein field and 
certainly many more will be transferred, adjusted, and applied to nucleic acids. There is a great 
need for the development of new methods to investigate metal ion binding to nucleic acids. 
Recent novel approaches include the use of electrospray ionization mass spectrometry (ESI-MS) 
[276]: Metal ion-nucleic acid complexes of the thrombin-binding aptamer of different 
concentration were fragmented in the gas-phase and such the binding affinities determined. 
Another recent approach makes use of a specifically placed nitroxide spin label in order to 
measure the distance to coordinated paramagnetic metal ions by EPR [168]. This latter method 
has been used repeatedly with proteins (e.g., [336–340]). It will be fascinating to see what other 
methods will come up in the near and also more distant future to help to solve the "mysteries" of 
metal ion binding to nucleic acids. 
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ABBREVIATIONS AND DEFINITIONS 
 
5'UTR 5' untranslated region 
AES atomic emission spectroscopy 
Bistris bis-(2-hydroxy-ethyl)-amino-tris(hydroxymethyl)-methane 
ENDOR electron-nuclear double resonance spectroscopy 
EPR electron paramagnetic resonance 
ER endoplasmic reticulum 
ESEEM electron spin echo envelope modulation 
ESI-MS electrospray ionization mass spectrometry 
EXAFS extended X-ray absorption fine structure 
FT-IR Fourier-transform infrared 
glmS glucosamine-6-phosphate activated ribozyme 
GNA glycol nucleic acid 
GTP guanosine 5'-triphosphate 
HDV hepatitits delta virus 
Hepes (N-(2-hydroxyethyl)-piperazine-N-2-ethanesulfonic acid 
HSQC heteronuclear singel quantum coherence 
IR infrared 
ITC isothermal titration calorimetry 
MD molecular dynamics 
MOPS 3-(N-morpholino)propanesulfonic acid 
MRD magnetic relaxation dispersion 
NAIM nucleotide analog interference mapping 
NLPB non-linear Poisson-Boltzmann 
NMR nuclear magnetic resonance 
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NOE nuclear Overhauser effect 
NOESY nuclear Overhauser effect spectroscopy 
NTPS nucleoside 5'--thiotriphosphate 
PAGE polyacrylamide gel electrophoresis 
PNA peptide nucleic acid 
RNase ribonuclease 
ROESY rotating frame Overhauser effect spectroscopy 
rRNA ribosomal RNA 
RzB trans cleaving derivative of the hammerhead ribozyme from the peach latent 
mosaic viroid (PLMVd) 
SRP signal recognition particle 
T5PNP  5-p-nitrophenylphosphate 
TFA thermodynamic fingerprint analysis 
Tris 2-amino-2-hydroxymethyl-propane-1,3-diol 
tRNA transfer RNA 
Wye wyosine, a natural analog of guanine 
XANES X-ray absorption near edge structure 
XAS X-ray absorption spectroscopy 
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Table 1.  Concentration of various metal ions in the ocean, mammalian cells, the extracellular 
space, as well as bacterial cells. The respective literature source is always given in the title row.  
Mn+ Seawater 
[42] 
[ppm] 
Seawater 
[43] 
[mM] 
Mammalian 
cell [43] 
[mM] 
Extracellular 
space [43] 
[mM] 
Bacterial 
cells [44] 
[mg/kg] 
Bacterial 
cytosol [41] 
[mM] 
Li+ 0.17      
Na+ 1.1 · 104 470 10 145 4.6 · 103  
K+ 3.9 · 102 10 140 5 115 · 103 > 10 
Rb+ 90      
Cs+ 3      
Be2+ 6 · 10–7      
Mg2+ 1.35 · 103 50 30a 1 7 · 103 > 10 
Ca2+ 4.1 · 102 10 1 4 5.1 · 103 0.1 
Sr2+ 375      
Ba2+ 425      
Cr2+ 5 · 10–4    4  
Mn2+ 2 · 10–3    260 10–2 
Fe2+ 3 · 10–3 1 · 10–4   170   0.1 
Co2+ 4 · 10–4 3.1 · 10–6   7.5 low 
Ni2+ 7 · 10–3 1 · 10–6    low 
Cu+      10–2 
Cu2+ 3 · 10–3 1 · 10–3   150  
Zn2+ 1 · 10–2 1 · 10–4   83 0.1 
Ru3+ 1 · 10–2      
Pd2+ 1 · 10-2      
Ag+ 7 · 10–2      
Cd2+ 0.2    31  
Pt2+ 1 · 10–2      
Au3+ 4 · 10–3      
Hg2+ 8 · 10–2      
Tl+ 0.5      
Pb2+ 13      
a  The free concentration of Mg2+ is about 1 mM. 
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FIGURE LEGENDS 
 
Figure 1.  The five most common nucleobases in RNA and DNA: Guanine (gua/G), cytosine 
(cyt/C), adenine (ade/A), thymine (thy/T) and uracil (ura/U) are drawn as present in canonical 
Watson-Crick or wobble base pairs (top). The phosphate sugar backbone of DNA and RNA is 
depicted below. The most common metal ion coordination sites are indicated by bold letters.  
Figure 2.  Views of different metal ion binding sites in nucleic acids.  (a) Two Mg2+ ions in the 
active site of a group II intron (light orange) coordinate the scissile bond of the substrate 
oligonucleotide (light green) (PDB ID 3G78; [341]).  (b) Buried K+ ion in its binding pocket as 
found in the crystal structure of a 58 nt long rRNA fragment (PDB ID 1HC8; [342]).  (c) Top and 
side view of a G-quadruplex structure with two K+ ions in its central channel (PDB ID 3IBK; 
[343]).  (d) [Co(NH3)6]
3+ bound to the major groove of two G·U pairs, the amine ligands are shown 
in light green (PDB ID 1AJF; [225]).  (e) Intrastrand cis-Pt(II) adduct with the Pt2+ coordinated to 
two guanine-N7 sites and two NH3 ligands shown in light green (PDB ID 1A84; [344]).  (f) Three 
consecutive Ag+-mediated imidazole base pairs (PDB ID 2KE8; [118]). All panels were prepared 
using pymol (www.pymol.org) and the indicated PDB IDs. 
Figure 3.  Mechanism of RNA cleavage by a classical in-line attack. The nucleophillic 2'-OH 
attacks the adjacent phosphodiester and the opposite 5'-OH is liberated upon formation of 2',3'-
cyclic phosphate in this SN2 reaction. The attacking nucleophile and the leaving group are 
positioned ideally in a 180° angle to achieve a maximum cleavage rate. 
Figure 4.  The use of NAIM analysis combined with thiorescue to identify metal ion binding sites 
in RNA. The example shown visualizes a phosphorothioate interference at position 2 and a 
nucleobase mutation at position 6 that both can be rescued by a thiophilic metal. The introduced 
thiophosphate group at position 5 cannot be rescued by the addition of a more thiophilic metal ion, 
indicating that this group undergoes another kind of crucial (but unknown) interaction within the 
three-dimensional architecture of the RNA. This Figure is adapted from [144]. 
Figure 5.  Signatures of metal ion binding to nucleic acids as observed in NMR spectra.  (a) Mg2+ 
interaction is indicated by chemical shift changes (titration from 0 mM, red, to 12 mM Mg2+, dark 
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blue). Line broadening indicates direct Mg2+ coordination. The panel is adapted from [7] and [252].  
(b) Selective line broadening is observed in a 1H NMR spectrum with increasing amounts of Mn2+ 
(titration from 0 μM, blue, to 210 μM, yellow).  (c) Coordination of a Ag+ ion causes a 86 Hz 
splitting of the imidazole N3 signal in a [1H,15N]-HSQC. Panel adapted from [118].  (d) Binding of 
[Co(NH3)6]3
+ can be observed by NOE crosspeaks between the protons of its ammine ligands (bulk 
resonance at 3.65 ppm) and the imino protons of a short RNA hairpin. 
Figure 6.  Depending on the exchange rate between two states and the respective resonances in 
their NMR spectrum, the two peaks fall together (top) or are clearly separated (bottom) as the two 
extremes. 
Figure 7.  Calculation of intrinsic affinity constants as deduced from chemical shift changes upon 
Mg2+ addition to a large RNA [7,9,10]. (a) Scheme of the iterative calculation procedure.  (b) Fit of 
the experimental data from H6 of U21 in a group II intron domain 6 after the first and the fifth 
iteration [7]. The data points shift to the left, as the available Mg2+ concentration for each site 
becomes smaller. Simultaneously the calculated intrinsic affinity constant increases from log KA1 = 
2.11 ± 0.09 to log KA5 = 2.52 ± 0.04 [7].  
Figure 8.  Anions bound to metal ion within nucleic acid structures.  (a) A chloride ion (pink) 
bridges two [Co(NH3)6]
3+ complexes in the crystal structure of the E.coli signal recognition particle 
(SRP) RNA (PDB ID 3LQX; [295]).  (b) A binuclear Mg2+ complex in the loop E motif is bridged 
by three water or hydroxide molecules, respectively (PDB ID 354D; [298]). The panels were 
prepared using pymol (www.pymol.org) and the indicated PDB IDs.  
Figure 9.  Buffers commonly employed in experiments of nucleic acids. All buffers are shown in 
their protonated form. 
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